Skip to content

Clinical Efficacy and Mechanisms of Different Modes of Repetitive Transcranial Magnetic Stimulation in Minors with ADHD

Clinical Efficacy and Mechanisms of Different Modes of Repetitive Transcranial Magnetic Stimulation in Minors with ADHD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123262
Enrollment
Unknown
Registered
2026-04-23
Start date
2026-05-10
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorder

Interventions

high-frequency treatment group:high-frequency rTMS
iTBS treatment group:iTBS
observation group:4-week observation +iTBS

Sponsors

West China Second Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. The informed consent form signed by the legal guardian and the research participants; 2. Age range: 8-18 years old; 3. Diagnosed with ADHD through the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5); 4. The patient's condition was stable before treatment, and the drug dosage remained stable for more than 1 month. Throughout the entire treatment process, there were no changes in the medication or other treatment methods.

Exclusion criteria

Exclusion criteria: 1. Left handedness; 2. Suffering from serious or unstable physical illnesses; 3. History of head injury or epilepsy; 4. Diagnosed with mental retardation, substance dependence or abuse (excluding nicotine and caffeine), bipolar disorder, obsessive-compulsive disorder, post-traumatic stress disorder, DSM-V defined eating disorders, and other illnesses; 5. Metal implants or any other means of activating or controlling implanted devices, implanted drug pumps, or intracardiac circuits within the body; 6. Taking benzodiazepine drugs; 7. Receive electrical convulsions and other stimuli within six months; 8. Visual or auditory impairments.

Design outcomes

Primary

MeasureTime frame
Attention Test;treatment compliance;Brain function;

Secondary

MeasureTime frame
Screening for Attention Deficit Hyperactivity Disorder Symptoms;cognitive function;Social function;

Countries

China

Contacts

Public ContactLiu Fang/Li Jing

West China Second Hospital of Sichuan University

971999462@qq.com+86 151 9664 0746

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026